Literature DB >> 22492129

Towards establishing MS prevalence in Latin America and the Caribbean.

M O Melcon1, C M Melcon, L Bartoloni, E Cristiano, J C Duran, A K Grzesiuk, Y D Fragoso, J B Bidin Brooks, V Díaz, K M Romero García, J A Cabrera Gomez, P Abad, M A Macías Islas, F Gracia, V F Hamuy Diaz de Bedoya, M E Córdova Ruiz, J H Hackembruch, C Oehninger, C N Ketzoian, A Soto.   

Abstract

A very high prevalence of multiple sclerosis (MS) has been reported in some Western European and North American countries. The few surveys of MS epidemiology in South America reveal lower prevalence rates, implying that susceptibility varies between distinct ethnic groups, thus forming an important determinant of the geographic distribution of the disease. The objective of this study is to review MS prevalence estimates in different Latin American and Caribbean countries. We reviewed surveys of regional MS prevalence from 1991 to 2011. Sources included an online database, authors' reports and proceedings or specific lectures from regional conferences. We obtained a total of 30 prevalence surveys from 15 countries, showing low/medium MS prevalence rates. Both the number and the quality of prevalence surveys have greatly improved in this region over recent decades. This is the first collaborative study to map the regional frequency of MS. Establishment of standardized methods and joint epidemiological studies will advance future MS research in Latin America and the Caribbean.

Entities:  

Mesh:

Year:  2012        PMID: 22492129     DOI: 10.1177/1352458512441985

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  12 in total

Review 1.  Do We Need Worms to Promote Immune Health?

Authors:  Joel V Weinstock
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

2.  Multiple sclerosis care in Latin America.

Authors:  Victor M Rivera; Marco Tulio Medina; Reyna M Duron; Miguel Angel Macias
Journal:  Neurology       Date:  2014-05-06       Impact factor: 9.910

3.  Absence of the tag polymorphism for the risk haplotype HLA-DR2 for multiple sclerosis in Wixárika subjects from Mexico.

Authors:  G V González-Enríquez; B M Torres-Mendoza; J Márquez-Pedroza; M A Macías-Islas; G G Ortiz; J A Cruz-Ramos
Journal:  Immunogenetics       Date:  2018-02-03       Impact factor: 2.846

4.  Orofacial evaluation in patients with multiple sclerosis using Nordic Orofacial Test-Screening.

Authors:  Marcela Leticia Leal Gonçalves; Cristiane Miranda França; Yara Dadalti Fragoso; Alessandro Melo Deana; Larissa Mateus de Almeida; Sandra Kalil Bussadori
Journal:  Clin Oral Investig       Date:  2016-09-06       Impact factor: 3.573

5.  HLA class I & II alleles in multiple sclerosis patients from Puerto Rico.

Authors:  María T Miranda; Erick Suárez; Muneer Abbas; Angel Chinea; Rafael Tosado; Ida A Mejías; Nawal Boukli; Georgia M Dunston
Journal:  Bol Asoc Med P R       Date:  2013

Review 6.  Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.

Authors:  Jorge Correale; Jose Flores; Juan Garcia Bonitto; Claudia Cárcamo Rodríguez; Enedina M L Oliveira
Journal:  Adv Ther       Date:  2015-07-14       Impact factor: 3.845

Review 7.  Prevalence of multiple sclerosis in Latin America and its relationship with European migration.

Authors:  Edgar Correa; Víctor Paredes; Braulio Martínez
Journal:  Mult Scler J Exp Transl Clin       Date:  2016-09-02

8.  Environmental factors influencing multiple sclerosis in Latin America.

Authors:  Jorge Correale; Mauricio F Farez; María Inés Gaitán
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-06-13

9.  Differences in utility scores obtained through Brazilian and UK value sets: a cross-sectional study.

Authors:  Maíra Libertad Soligo Takemoto; Nilceia Lopes da Silva; Ana Carolina Padula Ribeiro-Pereira; Arthur Orlando Correa Schilithz; Cibele Suzuki
Journal:  Health Qual Life Outcomes       Date:  2015-08-06       Impact factor: 3.186

10.  Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.

Authors:  Nilceia Lopes da Silva; Maira L S Takemoto; Alfredo Damasceno; Yara D Fragoso; Alessandro Finkelsztejn; Jefferson Becker; Marcus V M Gonçalves; Charles Tilbery; Enedina M L de Oliveira; Dagoberto Callegaro; Fernanda C Boulos
Journal:  BMC Health Serv Res       Date:  2016-03-24       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.